Development and validation of a rapid and reliable method for TPMT genotyping using real-time PCR

Area of Science:

• Pharmacogenomics
• Molecular diagnostics
• Clinical chemistry

Background:

• Inter-individual variability in drug response is linked to genetic polymorphisms in drug-metabolizing enzymes.
• Thiopurine S-methyltransferase (TPMT) polymorphism affects thiopurine drug metabolism, leading to potential severe myelosuppression in 11% of Caucasians.
• Accurate TPMT genotyping is crucial for safe and effective thiopurine therapy, particularly in leukemia treatment.

Purpose of the Study:

• To develop and validate a fast, reliable real-time PCR method for TPMT genotyping.
• To improve patient safety and treatment outcomes for thiopurine drugs.

Main Methods:

• DNA was extracted from 143 Caucasian individuals.
• Samples were genotyped for TPMT polymorphisms (*2, *3A, *3B, *3C) using real-time PCR.
• Real-time PCR results were validated against the established PCR-RFLP reference method.

Main Results:

• The real-time PCR method demonstrated 100% concordance, sensitivity, and specificity compared to PCR-RFLP.
• Commonly found TPMT mutant alleles (*2, *3B, *3C) were identified in 7.7% of the cohort.
• The new method reduced hands-on time by approximately two-thirds compared to standard PCR-RFLP.

Conclusions:

• A high-throughput real-time PCR method for TPMT genotyping was successfully established and optimized.
• This method accurately identifies common TPMT mutant alleles.
• The developed assay facilitates improved thiopurine drug management and reduces the risk of adverse drug reactions.